https://www.selleckchem.com/pr....oducts/Semagacestat(
In the mothers, detectable U-BMG (252 μg/L) was observed more frequently in the TDF- than AZT group (89 vs 50%, p less then 0.001), but other renal/bone parameters were similar. In infants, maternal TDF use was not associated with growth impairment, renal dysfunction, or abnormal bone findings, but with a slightly higher ALP levels (p = 0.019). However, shorter length was associated with maternal AZT (p = 0.021), and worse radiographic scores were associated with LPV/r (p = 0.024). In Vietnamese population, TDF usage